Skip to content
simvastatin

Structure via PubChem · Public domain (PubChem)

EntityQ670131· pop 39· linked from 462 articles

simvastatin

Sign in to save

Also known as MK-733, Zocor®, Zocor, 2,2-dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one, Cholestat, Sinvacor, Simcor

Simvastatin, sold under the brand name Zocor among others, is a statin, a type of lipid-lowering medication. It is used along with exercise, diet, and weight loss to decrease elevated lipid levels. It is also used to decrease the risk of heart problems in those at high risk. It is taken by mouth.

OverviewAI-generated

Simvastatin is a chemical compound with the formula C₂₅H₃₈O₅. It has a mass of 418.272 and a weight of 418.6. The substance possesses a charge of 0, an xlogp value of 4.7, and a topological polar surface area of 72.8. Its molecular structure includes one hydrogen bond donor and five hydrogen bond acceptors.

The defined daily dose for simvastatin is 30. The compound is referenced by 462 other encyclopedia articles.

Synthesized by Vinony from 18 facts across 4 sources: Wikidata, PubMed, PubChem, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.

Chemical data

Formula
C25H38O5
Molecular weight
418.6 g/mol
IUPAC name
[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate
SMILES
CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
InChIKey
RYMZZMVNJRMUDD-HGQWONQESA-N
XLogP
4.7
Polar surface area
72.8 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Research

13,209 papers

via PubMed

~14 min read

Encyclopedic overview

12 sections
Contents
  • Medical uses
  • Contraindications
  • Adverse effects
  • Interactions
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • History
  • Society and culture
  • Economics
  • Brand names
  • References

{{Drugbox | verifiedrevid = 464391842 | image = Simvastatin.svg | image_class = skin-invert-image | width = 200 | alt = | image2 = Simvastatin3Dan.gif | image_class2 = bg-transparent | width2 = 200 | alt2 = | pronounce = | tradename = Zocor, other | Drugs.com = | MedlinePlus = a692030 | DailyMedID = Simvastatin | pregnancy_AU = D | routes_of_administration = By mouth | ATC_prefix = C10 | ATC_suffix = AA01 | legal_AU = S4 | legal_UK = POM | legal_UK_comment = | legal_US = Rx-only | legal_US_comment = | legal_EU = Rx-only | legal_EU_comment = | bioavailability = 5% | protein_bound = 95% | metabolism = Liver (CYP3A4) | elimination_half-life = 2 hours for simvastatin and 1.9 hours for simvastatin acid | excretion = Kidney 13%, faecal 60% | IUPHAR_ligand = 2955 | CAS_number_Ref = | CAS_number = 79902-63-9 | PubChem = 54454 | DrugBank_Ref = | DrugBank = DB00641 | ChemSpiderID_Ref = | ChemSpiderID = 49179 | UNII_Ref = | UNII = AGG2FN16EV | KEGG_Ref = | KEGG = D00434 | ChEBI_Ref = | ChEBI = 9150 | ChEMBL_Ref = | ChEMBL = 1064 | IUPAC_name = (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate | C=25 | H=38 | O=5 | smiles = O=C(O[C@@H]1[C@H]3C(=C/[C@H](C)C1)\C=C/[C@@H]([C@@H]3CC[C@H]2OC(=O)C[C@H](O)C2)C)C(C)(C)CC | StdInChI_Ref = | StdInChI = 1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1 | StdInChIKey_Ref = | StdInChIKey = RYMZZMVNJRMUDD-HGQWONQESA-N }}

Simvastatin, sold under the brand name Zocor among others, is a statin, a type of lipid-lowering medication. It is used along with exercise, diet, and weight loss to decrease elevated lipid levels. It is also used to decrease the risk of heart problems in those at high risk. It is taken by mouth.

Excerpted from Wikipedia’s “simvastatin” article, available under the CC BY-SA 4.0 licence.